Evaluating the activity of temsirolimus in neuroendocrine cancer

Br J Cancer. 2007 Jan 15;96(1):177; author reply 178-9. doi: 10.1038/sj.bjc.6603513. Epub 2006 Dec 12.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Clinical Trials, Phase II as Topic
  • Disease Progression
  • Humans
  • Neuroendocrine Tumors / drug therapy*
  • Neuroendocrine Tumors / pathology
  • Sirolimus / analogs & derivatives*
  • Sirolimus / therapeutic use
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • temsirolimus
  • Sirolimus